No more routine liver tests for statin users
Most people taking statins are accustomed to having routine blood tests to watch for uncommon but serious liver-related side effects. But the rare cases of liver damage from statins aren't accurately predicted by routine blood testing. So, in March, the FDA recommended blood tests for liver function only when a person first starts taking a statin or if symptoms arise.
At the same time, the FDA strengthened label warnings on statins for two other possible side effects: increased blood sugar and temporary memory or cognitive lapses. The blood sugar concerns are supported by study data, while hard data on memory effects are still being collected. The risk of side effects seems to rise with increasing statin dose, and side effects usually stop when the drug is discontinued.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
